AI assistant
AVADEL PHARMACEUTICALS PLC — Director's Dealing 2023
Aug 11, 2023
31920_dirs_2023-08-11_6ba2df96-ff2a-46a5-ba57-18edf9e999a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2023-08-10
Reporting Person: Glass Geoffrey Michael (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-10 | ADSs | P | 14000 | $13.40 | Acquired | 59000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ADSs | 65700 | Indirect |
Footnotes
F1: The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
F2: These ADSs are held by The Geoffrey Glass Trust of which the reporting person is a co-trustee. The reporting person is the sole beneficiary of the trust.
F3: These ADSs are held by Geoffrey M. Glass Revocable Trust U/T/D August 26, 2020 of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.